Masatoshi Ogawa
- Co-authors
- H. OhmoriHiromi KumonKen‐ichi TomochikaSachiko GotôAkiyoshi TsujiYasuko KanekoHarutoshi OgaiJiro Kasahara
- Topics
- Antibiotic Resistance in Bacteria (4 papers)Parkinson's Disease Mechanisms and Treatments (3 papers)Probiotics and Fermented Foods (3 papers)
- Journals
- ScienceBiochemical and Biophysical Research CommunicationsToxicology and Applied Pharmacology
- Partner nations
- JapanUnited States
In The Last Decade
Masatoshi Ogawa
24 papers receiving 306 citations
Peers
Comparison fields: 5 of 98
- Molecular Biology 159
- Pharmacology 43
- Pharmacology 37
- Molecular Medicine 36
- Infectious Diseases 36
Countries citing papers authored by Masatoshi Ogawa
This map shows the geographic impact of Masatoshi Ogawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masatoshi Ogawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masatoshi Ogawa more than expected).
Fields of papers citing papers by Masatoshi Ogawa
This network shows the impact of papers produced by Masatoshi Ogawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masatoshi Ogawa. The network helps show where Masatoshi Ogawa may publish in the future.
Co-authorship network of co-authors of Masatoshi Ogawa
This figure shows the co-authorship network connecting the top 25 collaborators of Masatoshi Ogawa. A scholar is included among the top collaborators of Masatoshi Ogawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masatoshi Ogawa. Masatoshi Ogawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 4 | |
| 3 | 7 | |
| 4 | 4 | |
| 5 | 0 | |
| 6 | 7 | |
| 7 | 3 | |
| 8 | 96 | |
| 9 | 3 | |
| 10 | 2 | |
| 11 | IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITIES OF CS-807, A NEW ORAL CEPHALOSPORIN | 1 |
| 12 | 1 | |
| 13 | Bacteriological evaluation of a new oxacephem antibiotic, 6315-s (flomoxef) | 2 |
| 14 | Influence of dose schedule on efficacies of antibiotic combinations in Pseudomonas aeruginosa infection in mice. | 0 |
| 15 | ANTIBACTERIAL ACTIVITY OF HBK A NEW DERIVATIVE OF DIBEKACIN | 1 |
| 16 | 1 | |
| 17 | Bacteriological studies on sultamicillin | 0 |
| 18 | 1 | |
| 19 | LABORATORY EVALUATION OF CEFOXITIN, A BROAD SPECTRUM ANTIBIOTIC OF THE CEPHAMYCIN GROUP AND CEPHALOSPORINS | 1 |
| 20 | 102 |
About Masatoshi Ogawa
Masatoshi Ogawa is a scholar working on Molecular Medicine, Endocrinology and Filtration and Separation, having authored 29 papers that have together received 333 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (4 papers), Parkinson's Disease Mechanisms and Treatments (3 papers) and Probiotics and Fermented Foods (3 papers). The work is most often cited by research in Molecular Medicine (36 citations), Endocrinology (29 citations) and Pharmacology (43 citations). Masatoshi Ogawa has collaborated with scholars based in Japan and United States. Frequent co-authors include H. Ohmori, Hiromi Kumon, Ken‐ichi Tomochika, Sachiko Gotô, Akiyoshi Tsuji, Yasuko Kaneko, Harutoshi Ogai, Jiro Kasahara, Satoshi Goto and Yu Zhou. Their work appears in journals such as Science, Biochemical and Biophysical Research Communications and Toxicology and Applied Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.